0001914168-22-000001.txt : 20220301 0001914168-22-000001.hdr.sgml : 20220301 20220301153512 ACCESSION NUMBER: 0001914168-22-000001 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20220301 FILED AS OF DATE: 20220301 DATE AS OF CHANGE: 20220301 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Schlessinger Sam CENTRAL INDEX KEY: 0001914168 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39294 FILM NUMBER: 22697587 MAIL ADDRESS: STREET 1: 100 SOUTH SAUNDERS ROAD, SUITE 300 CITY: LAKE FORREST STATE: IL ZIP: 60045 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Assertio Holdings, Inc. CENTRAL INDEX KEY: 0001808665 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 850598378 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 S. SAUNDERS ROAD STREET 2: SUITE 300 CITY: LAKE FOREST STATE: IL ZIP: 60045 BUSINESS PHONE: (224) 419-7106 MAIL ADDRESS: STREET 1: 100 S. SAUNDERS ROAD STREET 2: SUITE 300 CITY: LAKE FOREST STATE: IL ZIP: 60045 3 1 wf-form3_164616689089723.xml FORM 3 X0206 3 2022-03-01 0 0001808665 Assertio Holdings, Inc. ASRT 0001914168 Schlessinger Sam 100 SOUTH SANDERS ROAD, SUITE 300 LAKE FORREST IL 60045 0 1 0 0 SVP, General Counsel Common Stock 16632 D Stock Option (right to buy) 1.31 2031-12-01 Common Stock 235000.0 D Restricted Stock Units 0.0 2024-10-01 Common Stock 58212.0 D Restricted Stock Units 0.0 2024-02-11 Common Stock 37878.0 D Restricted Stock Units 0.0 2023-08-05 Common Stock 14270.0 D One-third of these stock options are scheduled to vest on each of December 1, 2022, 2023, and 2024, assuming continued employment through the applicable vesting date. One-third of these restricted stock units are scheduled to vest on each of October 1, 2022, 2023, and 2024, assuming continued employment through the applicable vesting date. One-third of these restricted stock units are scheduled to vest on each of February 11, 2022, 2023, and 2024, assuming continued employment through the applicable vesting date. One-third of these restricted stock units are scheduled to vest on each of August 5, 2021, 2022, and 2023, assuming continued employment through the applicable vesting date. /s/ Sam Schlessinger 2022-03-01 EX-24 2 ex-24.htm PARKINSON AND SCHWICHTENBERG

POWER OF ATTORNEY
Assertio Holdings, Inc.

    The undersiged hereby constitutes and appoints Paul Schwichtenberg and Breelyn Parkinson,
individually, as the undersignedTMs true and lawful attorney-in-fact to:

(1) execute and deliver on behalf of the undersigned, in the undersigned's capacity as an
officer and/or director of Assertio Therapeutics, Inc., a Delaware corporation (the
Company), any and all documents relating to insider reporting requirements under
Section 16 of the Securities Exchange Act of 1934, including, without limitation, the
execution and filing of all Forms ID, 3, 4 and 5 (collectively, the Section 16 Filings),

(2) do and perform any and all acts for and on behalf of the undersigned which may be
necessary or desirable to complete and execute any such Section 16 Filings, complete and
execute any amendments thereto, and timely file such form with the United States
Securities and Exchange Commission and any stock exchange or similar authority; and

(3) take any other action of any type whatsoever in connection with the foregoing which, in
the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally
required by, the undersigned, it being understood that the documents executed by such
attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be
in such form and shall contain such terms and conditions as such attorney-in-fact may
approve in such attorney-in-fact's discretion.

    The undersigned hereby grants to the attorney-in-fact full power and authority to do and
perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the
exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the
undersigned might or could do if personally present, with full power of substitution or
revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-
fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this Power of
Attorney and the rights and powers herein granted. The undersigned acknowledges that the
foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not
assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply
with Section 16 of the Securities Exchange Act of 1934.

    This Power of Attorney shall remain in full force and effect until the undersigned is no
longer required to file Section 16 Filings with respect to the undersigned's holdings of and
transactions in securities issued by the Company, unless earlier revoked by the undersigned in a
signed writing delivered to the foregoing attorneys-in-fact.

    IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 25th day of February 2022.

/s/ Sam Schlessinger
__________________________
Sam Schlessinger